Indian bureaucrats and politicians must overcome short-term thinking and improve India's IP systems by ensuring that deserving products receive patents and making sure trademarks are enforced. Only then will India develop a true innovation economy.

India is on the brink of finalizing a free trade agreement with the European Union. Yet even as the deal gets close, one area remains hotly contested: protection for intellectual property (IP). Controversy mounts over "data exclusivity" for pharmaceuticals.

Recent court decisions in India endanger drug investment.

India has enormous potential for drug development if its legal system will respect intellectual property.

Adoption of a stakeholder approach is likely to undermine essentialresearch and developmentwhile doing little to curtail the HIV/AIDS epidemic.

The new Thai government is following the path of its predecessors, breaking drug patents and not spending enough on health.

If patent laws are thrown out in India's high court, it could jeopardize the world's patent system.

Counterfeit pharmaceuticals in Southeast Asia could pose a serious global health risk.